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Agenda 
• Recording and stimulus parameters 
• Normative data 
– Response prevalence and amplitude 
– Asymmetry ratio 
• Clinical data 
• Effect of aging 
• Effect of noise exposure 
• TBI/blast exposure 
 
cVEMP Recording and  
Stimulus Parameters 
AC cVEMP: Stimulus Frequency 
 
adapted from Akin, Murnane, Proffitt (2003) 
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Akin, Murnane, Proffitt (2003) 
TONE BURST LEVEL (dB pSPL) 
AC cVEMP: Stimulus Level 
Stimulus Parameters: AC cVEMP 
• Type:    500-Hz tone burst 
• Phase:    Rarefaction 
• Rise/Fall:   2 cycles 
• Plateau:   0 cycles 
• Gating:    Blackman 
• Level:    120 dB pSPL (90 dB nHL) 
• Rep Rate:   5/s 
 
cVEMP Amplitude is Proportional to SCM m. EMG Level 
Akin, Murnane, Panus, Caruthers, Wilkinson, Proffit, 2004 
Strategies to Account for the Effects of 
EMG Level on cVEMP Amplitude 
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SCM Muscle EMG Feedback 
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Control for EMG level during cVEMP recording by 
providing visual feedback to the patient 
Correct P1-N1 amplitude after cVEMP recording 
by using pre-stimulus baseline as a gross 
estimate of EMG level 
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Colebatch et al., 1994 
Corrected P1/N1 Amplitude 
oVEMP Recording and  
Stimulus Parameters 
AC oVEMP: Frequency 
Murnane, Akin, Kelly, Byrd, 2011 
AC oVEMP: Stimulus Level 
Murnane, Akin, Kelly, Byrd, 2011 
AC oVEMP Stimulus Parameters 
• Transducer:  ER-3A 
• Type:    500-Hz tone burst 
• Onset Phase:  Alternating  
• Rise/Fall:   2 ms 
• Plateau:   0 ms 
• Gating:    Blackman 
• Level:    125 dB pSPL 
• Rep. Rate:   5 Hz 
 
AC oVEMP: Gaze Elevation 
Murnane, Akin, Kelly, Byrd, 2011 
AC oVEMP  
Recording Parameters 
• No. of channels:  2  
• Amplifier gain:  100,000 x  
• Response filter:  1 – 1000 Hz 
• Sweep time:   50 ms 
• No. of sweeps:  500 
• Artifact rejection:   36 µV 
• Vertical gaze angle:  30° (midline)  
 
  
BC oVEMP: Stimulus Level 
BC oVEMP Stimulus Parameters 
• Amplifier:  B&K model 2718 
• Transducer:  B&K model 4810  
• Type:    500-Hz tone burst 
• Onset Phase:  rarefaction  
• Rise/Fall:   2 ms 
• Plateau:    0 ms 
• Gating:    Blackman 
• Level:    155 dB peak FL 
• Rep. Rate:   5 Hz 
 
 
Linear 
Acceleration  
at Mastoids 
0.05 (0.02) 0.04 (0.01) 
0.09 (0.03) 0.12 (0.07) 
0.27 (0.12) 0.29 (0.16) 
Mean linear acceleration  
at Fz: 20.0 g (0.99) 
BC oVEMP Recording Parameters 
• No. of channels:  2  
• Amplifier gain:  100,000 x  
• Response filter:  1 – 1000 Hz 
• Sweep time:   50 ms 
• No. of sweeps:  75  
• Artifact rejection:   off 
• Vertical gaze angle:  30° (midline)  
 
  
Normative Data 
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AC cVEMP Amplitude 
 
 
50 µV EMG 
 
Mean Age = 37 
years (±18) 
N = 252 Ears 
Mean P1/N1 = 124 µV (±78) 
AC cVEMP Asymmetry Ratio  
N = 115 subjects 
 
50 µV EMG 
BC oVEMP Amplitude 
Mean N1/P1 = 10.5 µV (±6) 
 
 
30° Vertical Gaze 
 
Mean Age = 35 
years (±17) 
N = 148 Eyes 
BC oVEMP Asymmetry Ratio 
N = 74 subjects 
 
30° Vertical Gaze 
Clinical Data 
Demographics 
 
• 312 consecutive patients referred to 
Vestibular Clinic 
 
• Age Range = 22 - 89 years (X = 60 ±15 yrs) 
 
 
VEMP Protocol 
• AC cVEMP 
– 500-Hz tone bursts at 120 dB pSPL (90 dB nHL) 
– 50 µV EMG  
• If no response, maximum voluntary contraction (MVC) 
– SSCD Screen at 65 dB nHL 
• BC oVEMP 
– 500-Hz tone bursts at 155 dB pFL 
– 30° vertical gaze angle 
• If no response, then maximum gaze angle 
 
AC cVEMP Amplitude:  
Patients vs. Healthy Individuals 
cVEMP Asymmetry Ratios in  
Clinic Patients 
N = 235 
BC oVEMP Amplitude:  
Patients vs. Healthy Individuals 
oVEMP Asymmetry Ratios in  
Clinic Patients 
N = 259 
VEMP Findings in Clinic Patients 
AC cVEMP 
N = 312 
BC oVEMP 
N = 289 
Normal Findings 
32%@ 50 µV EMG 61%@ 30°gaze 
28% @ MVC 17% @ max gaze 
Total 60% 78% 
Abnormal Findings 
AR > 40% 19% 11% 
     left/right 8/11% 5/7% 
Bilateral absence 12% 10% 
Total 31% 22% 
+ SSCD screen 2% N/A 
Could not test 11% 0.01% 
Effect of Aging on cVEMP 
Decrease in cVEMP amplitude in 
individuals > 60 years 
   Ochi and Ohashi 2003; Basta et al. 2005; Basta 
et al. 2007; Su et al. 2004; Welgampola and 
Colebatch 2001b; Zapala and Brey 2004; 
Brantberg, Granath, Schart 2007 
 
• Are amplitude decrements influenced by age-
related changes in the vestibular system or age 
related changes in SCM muscle? 
 
• 24 young individuals (22 – 31 years; X = 24 ± 3)  
• 24 older individuals (61 – 86 years; X = 70 ± 6) 
 
 
Akin, Murnane, Tampas, Clinard (2011). The 
effect of age on the vestibular evoked myogenic 
potential and sternocleidomastoid muscle tonic 
EMG level, Ear & Hearing 
 
Effect of Age on SCM m EMG Level 
 
Akin, Murnane, et al., 2011 
Akin, Murnane, Tampas, Clinard, 2011 
cVEMPs Recorded at Various EMG Levels  
Effect of Age on cVEMP Amplitude 
Akin, Murnane, Tampas, Clinard, 2011 
Age Trends for VEMP Clinic Findings 
Mean Age (years) 
AC cVEMP BC oVEMP 
NORMAL 57 ±15 59±15 
BILATERAL 65 ±12 67±11 
UNILATERAL 63 ±17 62±15 
CNT 65 ±17 70±8 
50 µV / 30° GAZE 52 ±16 58±15 
MVC/ MAX GAZE 63 ±12 64±13 
Effect of Noise Exposure on cVEMP 
Effect of Noise Exposure on cVEMP 
Akin, Murnane et al. 2012   The Effect of 
Noise Exposure on the cVEMP 
 
 
43 subjects with 
asymmetric NIHL and 
history of asymmetric 
noise exposure          
(25 – 63 years, X = 52 yrs) 
14 age-matched controls 
(Poorer-Hearing Ear P1-N1 – Better-Hearing Ear P1-N1)  X 100 
(Poorer-Hearing Ear P1-N1 + Better-Hearing Ear P1-N1) 
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Asymmetry Ratios:   
Control and Noise Exposure Groups 
Akin, Murnane et al., 2012 
Asymmetry Ratios:   
Control and Noise Exposure Groups 
Akin, Murnane et al., 2012 
Asymmetry Ratios:   
Control and Noise Exposure Groups 
Akin, Murnane et al., 2012 
Asymmetry Ratios:   
Control and Noise Exposure Groups 
Akin, Murnane et al., 2012 
Asymmetry Ratios:   
Control and Noise Exposure Groups 
Akin, Murnane et al., 2012 
33% 
Akin, Murnane et al., 2011 
Are there differences in hearing loss between noise-
exposed subjects with cVEMPs present and the 
noise-exposed subjects with cVEMPs absent? 
 
Effect of mTBI/Blast Exposure 
 
N 
 
hSCC 
Otolith  
organ 
Ocular  
motor 
Gait/ 
balance 
Davies & Luxon 1995 100 51% - 8% - 
Ernst et al. 2005 63 19% 25% 5% 27% 
Dae Lee et al. 2011 28 7% 54% - - 
Shupak et al. 1993 5 40% - - - 
Van Campen et al. 1999 30 7% - 7% 37% 
Cohen et al. 2002 17 0% - - 4% 
Scherer et al. 2011* 11 27% 17% 45% - 
Literature Review:  
Abnormal vestibular function test findings in  
individuals with dizziness/imbalance related to  
TBI/blast exposure 
TBI/Blast 
N = 51 
Control  
N = 21 
Age  37 (10) 26 (5) 
MMSE 29 (1.8) 30 (.4) 
PTSD 92% 0% 
Tinnitus 98% 14% 
Sensorineural 
Hearing Loss 
67% 0% 
Mountain Home VAMC Study:  
Preliminary Findings 
Symptom  N (%) 
Vertigo 25 (49%) 
Imbalance 45 (88%) 
Lateropulsion 26 (52%) 
Lightheadedness 37 (73%) 
Oscillopsia 3 (6%) 
Symptom Characteristics of mTBI/Blast Group (n = 51)  
Number  
of  blasts 
Number  
of Veterans 
0 3 
1-2 13 
3-5 6 
5+ 29  
History of Blast Exposure for 51 Veterans 
Time since worst exposure 
Range = 6 months – 10 years 
Mean (SD) = 5 years 9 mos (30 mos) 
4 Veterans  with symptoms ≥ 20 years 
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cVEMP Amplitude in mTBI/Blast 
and Control Groups 
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cVEMP Asymmetry Ratios in 
Control and mTBI/Blast Groups 
Future Directions 
• Role of VEMPs in diagnosis of common 
vestibular disorders – need clinical trials 
• How do VEMPs correlate with patient 
symptoms and other tests of vestibular 
function? 
• How does otolith loss affect postural stability 
and rehabilitation outcomes? 
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